A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/513 (2006.01) A61K 9/30 (2006.01) A61K 9/56 (2006.01) A61P 9/10 (2006.01)
Patent
CA 2537178
The present invention provides enteric polymer coated tablet formulations for oral administration which comprise a phospholipase A2 enzyme Lipoprotein Associated Phospholipase A2 (Lp-PLA2) inhibitor, processes for preparing such formulations and their use in therapy, in particular the treatment of atherosclerosis.
L'invention porte sur un comprimé pharmaceutique à administration orale comprenant un inhibiteur de l'enzyme Lp-PLA2 (phospholipase A2 associée à une lipoprotéine), sur son procédé de préparation, et sur ses utilisations thérapeutiques, en particulier pour le traitement de l'athérosclérose.
Glaxo Group Limited
Gowling Lafleur Henderson Llp
LandOfFree
Pharmaceutical formulation comprising a pyrimidine-a-one... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical formulation comprising a pyrimidine-a-one..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical formulation comprising a pyrimidine-a-one... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1515317